A registered study indexed because it matched monitored longevity research terms. Registry status: Active Not Recruiting. Registration does not establish safety or effectiveness.
What the source actually supports
- Evidence stage
- Phase not reported
- Study design
- RANDOMIZED · PARALLEL · TREATMENT · TRIPLE
- Evidence population
- Human clinical study registration
- Participants
- 192
- Population
- ALL · 60 Years to 85 Years
- Duration
- 2023-07-17 to 2026-12-10
- Intervention
- Shanyu pill; Placebo
- Comparator
- Placebo group
- Outcomes measured
- Change From Baseline in Appendicular Skeletal Muscle Mass Index (ASMI) — Baseline, Week 12, Week 24, and 2 years after…; Change From Baseline in Handgrip Strength — Baseline, Week 12, Week 24, and 2 years after completion of the 24-week int…; Change From Baseline in Five-Times Sit-to-Stand Test Performance — Baseline, Week 12, Week 24, and 2 years after comple…; Change From Baseline in Traditional Chinese Medicine Syndrome Score for Spleen Qi Deficiency — Baseline, Week 12, Week…; Change From Baseline in Gut Microbiota Composition — Baseline, Week 24, and 2 years after completion of the 24-week int…; Change From Baseline in Cortical Hemodynamic Responses Assessed by Functional Near-Infrared Spectroscopy — Baseline, We…; Change From Baseline in Gait Speed — Baseline, Week 12, Week 24, and 2 years after completion of the 24-week interventi…; Change From Baseline in 6-Minute Walk Distance — Baseline, Week 12, Week 24, and 2 years after completion of the 24-wee…; Change From Baseline in Short Physical Performance Battery Score — Baseline, Week 12, Week 24, and 2 years after comple…; Change From Baseline in Timed Up and Go Test Completion Time — Baseline, Week 12, Week 24, and 2 years after completion…; Change From Baseline in Montreal Cognitive Assessment Score — Baseline, Week 12, Week 24, and 2 years after completion…; Change From Baseline in Stroop Color-Word Test Completion Time — Baseline, Week 12, Week 24, and 2 years after completi…; Change From Baseline in Stroop Color-Word Test Accuracy — Baseline, Week 12, Week 24, and 2 years after completion of t…; Change From Baseline in Relative Abundance of Metabolites Detected by Untargeted Metabolomics — Baseline, Week 24, and…
- Reported result
- No reusable finding-level result is available in this record.
Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.
Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.
Source supportStructured registry protocol metadata; no finding-level conclusion is generated.
Registration and recruitment status do not establish safety, efficacy, or regulatory approval.
Why this record appears here · 100% topic match
The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.
- Sarcopenia · 100%Title contains controlled term: sarcopenia. Abstract contains controlled term: sarcopenia. Source terminology contains: sarcopenia. Title supplies longevity context: older adult. Study type is explicitly identified as INTERVENTIONAL.
Automated source check 100% · update recency 100%. These figures help sort records; they are not medical ratings.